RecruitingPhase 2 / Phase 3NCT07176546
Rare condition
Granulomatosis with polyangiitis
24
studies recruiting now
as of 7 Sept 2026
136
studies registered in total
as of 7 Sept 2026
17
countries with a recruiting site
as of 7 Sept 2026
3 Mar 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT00315380
Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis
RecruitingPhase 3NCT06512883
A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
RecruitingPhase 3NCT07444567
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
RecruitingPhase 4NCT07087912
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 24 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Granulomatosis with polyangiitis study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Granulomatosis with polyangiitis
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (HLA-DPA1, HLA-DPB1, CTLA4, PTPN22, PRTN3).
Treatments being studied
2 approved treatments and 13 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Rituximab (Blitzima)Approved: Avacopan (Tavneos)
Phase 3Prednisone (Cortan)
Phase 3Mepolizumab (Bosatria)
Phase 3Abatacept (Orencia)
Phase 3Azathioprine (Azamune)
Phase 3Cyclophosphamide (Cyclophosphamide)
Phase 2/3Etanercept (Benepali)
Phase 2Gusperimus
Phase 2Daclizumab (Zenapax)
+ 5 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).